Shingles vax should be priority for JAK inhibitor treated  patients

Shingles vaccination should be considered for older patients with rheumatoid arthritis, according to European researchers who have shown that JAK inhibitor therapy is associated with an almost four-fold higher risk of herpes zoster compared to conventional synthetic DMARDs. German investigators reviewed the risk of herpes zoster in almost 14,000 patients with rheumatoid arthritis receiving DMARD ...

Already a member?

Login to keep reading.

© 2021 the limbic